Table 4 Univariate regression analysis of possible predictors for aortic AIx (AP/PP) normalized for a heart rate of 75/min in all study subjects (n = 122)
From: Increased augmentation index in patients with Ehlers-Danlos syndrome
Variable | Coefficient | 95% Confidence Interval | p-value |
|---|---|---|---|
Age, years | 0.43 | 0.27 to 0.59 | < 0.001 |
Male sex, (yes/no) | −13.36 | −17.96 to −8.76 | < 0.001 |
Height, cm | −0.61 | −0.80 to −0.42 | < 0.001 |
Weight, kg | −0.21 | − 0.36 to − 0.06 | 0.007 |
BMI, kg/m2 | 0.19 | −0.40 to 0.78 | 0.532 |
Ehlers-Danlos Syndrome, (yes/no) | 8.10 | 3.59 to 12.60 | 0.001 |
Mean systolic blood pressure, mmHg | 0.124 | −0.05 to 0.30 | 0.168 |
Mean diastolic blood pressure, mmHg | 0.42 | 0.22 to 0.61 | < 0.001 |
Smoking, (yes/no) | 2.78 | −3.18 to 8.79 | 0.357 |
Pack years of smoking, n | 0.41 | 0.12 to 0.69 | 0.006 |
Antihypertensive Drugs, (yes/no) | 8.67 | 0.55 to 16.79 | 0.037 |
Antiplatelet Drugs, (yes/no) | −5.88 | −32.13 to 20.37 | 0.658 |
NSAID, (yes/no) | 7.03 | −0.07 to 14.19 | 0.052 |